Maxwell Biosciences makes progress in infectious disease treatment
Live Forever Club - 19-Feb-2025Investors are taking interest as the company moves toward human trials
Join the club for FREE to access the whole archive and other member benefits.
Investors are taking interest as the company moves toward human trials
Promising preclinical results suggest a clear path towards drug development
In Phase IIb trials, plasma biomarkers identify early-stage patients
Dual-action therapies tackling inflammation, metabolism, and neurodegeneration
New Spiroligomer™ technology opens pathways to treating previously untargetable diseases
Click on resource name for more details.
Pioneering the next generation of antibody therapeutics for hard to treat diseases
26-Aug-2024 to 30-Aug-2024
Event about latest progress in the molecular, cellular and organismal basis of aging organised by University of Copenhagen (Copenhagen, Denmark)
No blog posts found!